Side-by-side comparison of AI visibility scores, market position, and capabilities
NYC direct-to-consumer fresh dog food with USDA-inspected human-grade proteins and UnKibble slow-dried line; competing with The Farmer's Dog and Ollie for premium personalized pet food subscription market.
Spot & Tango is a New York-based direct-to-consumer fresh dog food company delivering personalized, human-grade meals made with USDA-inspected whole proteins, vegetables, and grains — formulated by veterinary nutritionists and prepared in USDA-certified kitchens without fillers, by-products, artificial preservatives, or rendered meals. Founded in 2018 and competing in the premium pet food market, Spot & Tango customizes each subscription based on the dog's breed, age, weight, activity level, and health conditions — competing with The Farmer's Dog, Ollie, and Nom Nom for the growing share of dog owners shifting from kibble to fresh food for health-conscious pet care.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.